Znanstveni rad - Izvorni znanstveni rad
Effects of trastuzumab and trastuzumab emtansine on corrected QT interval and left ventricular ejection fraction in patients with metastatic (HER2+) breast cancer
The Egyptian Heart Journal, 75 (2023), 1; 11. https://doi.org/10.1186/s43044-023-00331-y

Levicki, Rea; Lovrić Benčić, Martina; Ivanac Vranešić, Irena; Bradić, Lada; Begovac, Marta; Jug, Juraj; Dedić Plavetić, Natalija

Citirajte ovaj rad

Levicki, R., Lovrić Benčić, M., Ivanac Vranešić, I., Bradić, L., Begovac, M., Jug, J. i Dedić Plavetić, N. (2023). Effects of trastuzumab and trastuzumab emtansine on corrected QT interval and left ventricular ejection fraction in patients with metastatic (HER2+) breast cancer. The Egyptian Heart Journal, 75. (1). doi: 10.1186/s43044-023-00331-y

Levicki, Rea, et al. "Effects of trastuzumab and trastuzumab emtansine on corrected QT interval and left ventricular ejection fraction in patients with metastatic (HER2+) breast cancer." The Egyptian Heart Journal, vol. 75, br. 1, 2023. https://doi.org/10.1186/s43044-023-00331-y

Levicki, Rea, Martina Lovrić Benčić, Irena Ivanac Vranešić, Lada Bradić, Marta Begovac, Juraj Jug i Natalija Dedić Plavetić. "Effects of trastuzumab and trastuzumab emtansine on corrected QT interval and left ventricular ejection fraction in patients with metastatic (HER2+) breast cancer." The Egyptian Heart Journal 75, br. 1 (2023). https://doi.org/10.1186/s43044-023-00331-y

Levicki, R., et al. (2023) 'Effects of trastuzumab and trastuzumab emtansine on corrected QT interval and left ventricular ejection fraction in patients with metastatic (HER2+) breast cancer', The Egyptian Heart Journal, 75(1). doi: 10.1186/s43044-023-00331-y

Levicki R, Lovrić Benčić M, Ivanac Vranešić I, Bradić L, Begovac M, Jug J, i sur.. Effects of trastuzumab and trastuzumab emtansine on corrected QT interval and left ventricular ejection fraction in patients with metastatic (HER2+) breast cancer. The Egyptian Heart Journal [Internet]. 13.02.2023. [pristupljeno 09.07.2024.];75(1). doi: 10.1186/s43044-023-00331-y

R. Levicki, et al., "Effects of trastuzumab and trastuzumab emtansine on corrected QT interval and left ventricular ejection fraction in patients with metastatic (HER2+) breast cancer", The Egyptian Heart Journal, vol. 75, br. 1, Veljača 2023. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:105:806284. [Citirano: 09.07.2024.]

Prijavite se u repozitorij kako biste mogli spremiti objekt u svoju listu.